Boji Medical Technology Co.,Ltd.

SZSE:300404 Stock Report

Market Cap: CN¥3.4b

Boji Medical TechnologyLtd Future Growth

Future criteria checks 5/6

Boji Medical TechnologyLtd is forecast to grow earnings and revenue by 39.2% and 24% per annum respectively. EPS is expected to grow by 38.5% per annum. Return on equity is forecast to be 10% in 3 years.

Key information

39.2%

Earnings growth rate

38.5%

EPS growth rate

Life Sciences earnings growth32.9%
Revenue growth rate24.0%
Future return on equity10.0%
Analyst coverage

Low

Last updated19 Sep 2024

Recent future growth updates

No updates

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Nov 02
We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Oct 08
A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

May 01
Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Mar 06
Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Earnings and Revenue Growth Forecasts

SZSE:300404 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,230127N/A632
12/31/2025957100N/A1202
12/31/202473872N/A522
9/30/202475345-1022N/A
6/30/202466537648N/A
3/31/202462029-3120N/A
12/31/202355624-2636N/A
9/30/202350429-6818N/A
6/30/202348130-1020N/A
3/31/202345327-10215N/A
1/1/202342428-9028N/A
9/30/202238827-7923N/A
6/30/202237940-4540N/A
3/31/202234344-3036N/A
1/1/202232439-2430N/A
9/30/2021298311158N/A
6/30/2021271192164N/A
3/31/20212953068105N/A
12/31/2020260176697N/A
9/30/2020259201855N/A
6/30/202024116537N/A
3/31/2020209-1-37-5N/A
12/31/20192247-290N/A
9/30/20192017123N/A
6/30/20191895532N/A
3/31/20191774-2211N/A
12/31/20181727-1127N/A
9/30/2018155-16-2227N/A
6/30/2018153-19N/A32N/A
3/31/2018152-16N/A53N/A
12/31/2017131-24N/A26N/A
9/30/2017121-3N/A-3N/A
6/30/20171034N/A-19N/A
3/31/201774-1N/A-28N/A
12/31/2016722N/A-34N/A
9/30/20168111N/A-19N/A
6/30/20168812N/A-18N/A
3/31/201611122N/A-2N/A
12/31/201512726N/A2N/A
9/30/201515039N/A35N/A
6/30/201515339N/A37N/A
3/31/201514839N/A28N/A
12/31/201414438N/A26N/A
12/31/201313635N/A43N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300404's forecast earnings growth (39.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 300404's earnings (39.2% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 300404's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300404's revenue (24% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 300404's revenue (24% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 300404's Return on Equity is forecast to be low in 3 years time (10%).


Discover growth companies